Portrait Affina Immuntechnik GmbH develops produces and sales innovative immune adsorbers for the treatment of autoimmune diseases. Extracorporeal immunoadsorption is a new treatment method removing disease-related autoantibodies from patient's blood. Affina has two products in the market: GlobaffinŽ for treatment of e.g. rheumatoid arthritis and CoraffinŽ for the heart disease DCM.
Top
Print version
PDF version
Recommend company